Project Grant R01DA060742
- The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $397,829 Project Grant to Callentis Consulting Group LLC, a woman-owned small business in Austin, Texas. The grant, awarded on May 1, 2025, supports the development of an artificial intelligence (AI) platform to discover new therapeutics for substance use disorders. The key products and services to be delivered include: 1) Curated training datasets and machine learning...
- The National Institute on Drug Abuse (NIDA) awarded a $164,000 Project Grant to The Trustees of Princeton University for the development of a "Chemical AI and Data Science Platform for the Identification and Discovery of Novel Psychoactive Substances." The 2-year project, running from August 2025 to July 2027, aims to create a comprehensive database of known novel psychoactive substances (NPS) and leverage artificial intelligence (AI) tools to predict the structure and mass...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $363,310 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Vermont & State Agricultural College (UVM). The grant, titled "The Healthy Brain and Child Development Study's Scientific Training in Addiction Research Techniques Program (HBCD-START)," will provide comprehensive research education and training to prepare investigators to...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $159,625 Project Grant under CFDA 93.279 - Drug Use and Addiction Research Programs to the University of Texas at Austin. The funding will support a 2-year research study examining the effects of punishment on future drug use behaviors, specifically focusing on age and sex differences in reward responsiveness after punishment. The study aims to establish the validity of a rodent model for...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $558,668 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Massachusetts Institute of Technology (MIT) for the project "Integration and Validation of Single-Cell Neuronal and Immune Molecular Responses in SUD and HIV". The project aims to uncover the genetic and molecular mechanisms driving the interactions between HIV, neuropsychiatric, and...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,080,885 to the University of Southern California (USC) from September 2024 to September 2027. The funding supports the development of novel neural network models that can capture the nonlinear dynamics of large-scale brain networks and their relationship to behavior. The models will have flexible inference capabilities, enabling real-time,...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $608,652 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Scripps Research Institute. The purpose of this 5-year award, with a start date of September 1, 2025, is to conduct data mining and functional validation of the Systematic Characterization of Retroviral Conditions for Health (SCORCH) datasets. The research aims to elucidate the key pathogenic...
- The National Institute on Drug Abuse (NIDA) awarded a $569,743 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Yale University on July 15, 2025. The grant, titled "Y-SCORCH 2.0: Further Data Mining and Functional Characterization for Single Cell Opioid Responses in the Context of HIV (SCORCH) Program," aims to leverage advanced tools to analyze transcriptomic and epigenetic data from the SCORCH consortium and novel spatial transcriptomic data to...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $707,108 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Regents of the University of California, Berkeley (UC Berkeley) for the "International Development Project (IDP): An International Collaboration for the Standardized Study of Experience-Dependent Brain and Behavioral Development". The project aims to study the effects of various forms of...
- This federal Project Grant award of $811,112 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the network and circuit dynamics underlying dopaminergic control of sudden insight learning. The principal investigator and research team at the University of California, San Francisco (UCSF) will use a combination of large-scale two-photon calcium imaging, high-density electrophysiology, dopamine sensor fiber...
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $407,382 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Texas at Austin (UT Austin). The grant, titled "REPRESENTATIONAL GEOMETRY: EVALUATING BRAIN-COMPUTATIONAL MODELS WITH NEURAL ACTIVITY DATA", will fund a collaboration between theorists and experimentalists to develop rigorous methods for evaluating and comparing complex brain computational models against neural activity data. The project aims to address key conceptual and technical challenges in estimating representational geometry from neural response data, which is critical for deepening our understanding of the neural circuit computations underlying perception, cognition, and behavior. The project will be conducted at UT Austin from August 1, 2025, through April 30, 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $407.4k | 7/31/25 |